SOLIGENIX, INC. Line of Credit Facility, Commitment Fee Percentage
SOLIGENIX, INC. (SNGX) reported Line of Credit Facility, Commitment Fee Percentage of 3.00% for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityCommitmentFeePercentage · last filed 2017-03-27
- 2015-09-30: Line of Credit Facility, Commitment Fee Percentage 9 month 3.00%.
- 2015-07-29: Line of Credit Facility, Commitment Fee Percentage 1 month 3.00%.
| Period end | Line of Credit Facility, Commitment Fee Percentage 1 month | Line of Credit Facility, Commitment Fee Percentage 9 month |
|---|---|---|
| 2015-09-30 | 3.00% 10-Q · filed 2015-11-12 | |
| 2015-07-29 | 3.00% 10-K · filed 2017-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |